Assessment of the Effectiveness of Chemotherapy Teaching: BrUOG 258



Status:Completed
Conditions:Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:5/5/2014
Start Date:October 2011
End Date:October 2013
Contact:Kayla Rosati
Email:Kayla_Rosati@brown.edu
Phone:401-863-3000

Use our guide to learn which trials are right for you!

This study will evaluate whether chemotherapy teaching sessions improves patient's
knowledge, preparedness and anxiety in relation to chemotherapy. This study will also
evaluate the effect of age, race, native language, education level, type of cancer and
chemotherapy regimen on the oncology teaching session.

Chemotherapy teaching sessions, often coordinated in the outpatient setting by nursing
personnel, are meant to educate patients about the chemotherapy they will be receiving.
Education topics include an understanding of side effects, treatment schedule, medications
to treat side effects and how to contact the oncology team if adverse events develop. Some
of these issues are addressed in the American Society of Clinical Oncology's Quality
Oncology Practice Initiative (QOPI). This study will perform an analysis of the teaching
process that is provided prior to chemotherapy administration.

This study will provide data for each participating hospital to individually assess their
teaching process. Multivariate analysis can be performed to evaluate whether age, sex,
native, language, race highest level of education, cancer type, chemotherapy regimen,
institution where chemotherapy will be administered, and type of personnel performing the
teaching visit, influences the effectiveness of the teaching visit. In addition, results
can be compared across different hospitals.This analysis may lead to improvements in each
hospital's chemotherapy teaching practices and lead to advances in patient's cognitive and
emotional preparedness.

Inclusion Criteria:

- Patients > 18 years of age who will be receiving chemotherapy (including targeted
anticancer therapy) at a Brown University Oncology Research Group Affiliated Hospital
for a period of 1-year after study activation.

- Patients who will be undergoing a chemotherapy teaching session at an institution
affiliated with the Brown University Oncology Research Group.

- No prior chemotherapy or targeted anticancer treatment.

- Signed informed consent

Exclusion Criteria:

Patients must meet eligibility criteria
We found this trial at
4
sites
593 Eddy Street
Providence, Rhode Island 02903
401-444-4000
Rhode Island Hospital Founded in 1863, Rhode Island Hospital in Providence, RI, is a private,...
?
mi
from
Providence, RI
Click here to add this to my saved trials
Pawtucket, Rhode Island 02860
?
mi
from
Pawtucket, RI
Click here to add this to my saved trials
164 Summit Ave
Providence, Rhode Island 02906
(401) 793-2500
Miriam Hospital The Miriam Hospital is a private, not-for-profit hospital, with a history of providing...
?
mi
from
Providence, RI
Click here to add this to my saved trials
Providence, Rhode Island 02908
?
mi
from
Providence, RI
Click here to add this to my saved trials